Observational studyViruses2025

Evaluation of Treatment Response in Chronic Hepatitis C Patients Receiving Sofosbuvir/Velpatasvir/Voxilaprevir: A Multicenter Real-World Experience from Türkiye.

Umut Devrim Binay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.